Maturitas
Volume 56, Issue 2 , Pages 122-128 , 20 February 2007

The effect of hormone therapy on the health-related quality of life in elderly women

  • Sirpa Eviö

      Affiliations

    • Department of Obstetrics and Gynecology, Helsinki University Central Hospital, PB 140, 00029 Helsinki, Finland
    • Corresponding Author InformationCorresponding author.
    • ,
  • Tuula Pekkarinen

      Affiliations

    • Department of Internal Medicine, Helsinki University Central Hospital, Peijas Hospital, Vantaa, Finland
    • ,
  • Harri Sintonen

      Affiliations

    • Department of Public Health, University of Helsinki, Helsinki, Finland
    • ,
  • Aila Tiitinen

      Affiliations

    • Department of Obstetrics and Gynecology, Helsinki University Central Hospital, PB 140, 00029 Helsinki, Finland
    • ,
  • Matti J. Välimäki

      Affiliations

    • Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland

Received 10 March 2006 ,Revised 1 June 2006 ,Accepted 9 June 2006.

References 

  1. Zichella L. Clinical management of the menopausal woman. Int J Fertil Menopausal Stud. 1993;38(Suppl. 1):15–22
  2. Oldenhave A, Jaszmann LJ, Haspels AA, Everaerd WT. Impact of climacteric on well-being. A survey based on 5213 women 39 to 60 years old. Am J Obstet Gynecol. 1993;168:772–780
  3. Wiklund I, Berg G, Hammar M, Karlberg J, Lindgren R, Sandin K. Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women. Maturitas. 1992;14(3):225–236
  4. Genazzani AR, Nicolucci A, Campagnoli C, et al. Assessment of the QoL in Italian menopausal women: comparison between HRT users and non-users. Maturitas. 2002;42(4):267–280
  5. Daly E, Gray A, Barlow D, McPherson K, Roche M, Vessey M. Measuring the impact of menopausal symptoms on quality of life. BMJ. 1993;307(6908):836–840
  6. Zethraeus N, Johannesson M, Henriksson P, Strand RT. The impact of hormone replacement therapy on quality of life and willingness to pay. Br J Obstet Gynaecol. 1997;104(10):1191–1195
  7. Sintonen H, Johansson S, Ohinmaa A, Apajasalo M, Kainulainen P, Heikkinen J. Measuring health-related quality of life in women on hormone replacement therapy. Expert Rev Pharmacoeconomics Outcomes Res. 2003;3(3):351–361
  8. Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med. 2003;348(19):1839–1854
  9. Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the heart and Estrogen/Progestin replacement study (HERS) trial. JAMA. 2002;287(5):591–597
  10. Sintonen H. The 15D instrument of health-related quality of life: Properties and applications. Ann Med. 2001;33(5):328–336
  11. Sintonen H. Outcome measurement in acid-related diseases. PharmacoEconomics. 1994;5(Suppl. 3):17–24
  12. Stavem K. Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease. Qual Life Res. 1999;8(1–2):45–54
  13. Hawthorne G, Richardson J, Day NA. A comparison of the assessment of quality of life (AQoL) with four other generic utility instruments. Ann Med. 2001;33(5):358–370
  14. Tobin J. Estimation of relationships for limited dependent variables. Econometrica. 1958;26:24–36
  15. Austin PC, Escobar M, Kopec JA. The use of the Tobit model for analyzing measures of health status. Qual Life Res. 2000;9:901–910
  16. Ylikangas S, Sintonen H, Heikkinen J. Decade-long use of continuous combined hormone replacement therapy is associated with better health-related quality of life in postmenopausal women, as measured by the generic 15D instrument. J Br Menopause Soc. 2005;11(4):145–151
  17. Komulainen M, Kroger H, Tuppurainen MT, Heikkinen AM, Honkanen R, Saarikoski S. Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial. Osteoporos Int. 2000;11(3):211–218
  18. Torgerson DJ, Bell-Syer SE. Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. JAMA. 2001;285(22):2891–2897
  19. Wells G, Tugwell P, Shea B, et al. Meta-analyses of therapies for postmenopausal osteoporosis. V. meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev. 2002;23(4):529–539
  20. Manson JE, Martin KA. Clinical practice. Postmenopausal hormone-replacement therapy. N Engl J Med. 2001;345(1):34–40

PII: S0378-5122(06)00231-3

doi: 10.1016/j.maturitas.2006.06.009

Maturitas
Volume 56, Issue 2 , Pages 122-128 , 20 February 2007

Article Tools

* Image Usage & Resolution